| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19.6M | -11.6% | -13.0% |
| R&D Expense | $30K | +76.5% | -30.2% |
| SG&A Expense | $21.7M | -4.1% | +21.0% |
| Operating Income | -$16.8M | -20.7% | -27.2% |
| Interest Expense | $4.0M | +15.0% | +28.5% |
| Pre-tax Income | -$15.3M | +62.9% | -21.8% |
| Income Tax | $39K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $28.8M | +27.8% | -48.7% |
| Short-term Investments | $117.7M | +65.2% | +1559.7% |
| Accounts Receivable | $4.0M | -42.5% | -61.4% |
| Inventory | $0 | — | — |
| Current Assets | $201.0M | +44.8% | +88.8% |
| Total Assets | $380.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.0M | — | — |
| Investing Cash Flow | -$110.4M | — | — |
| Financing Cash Flow | $144.9M | — | — |
| +11.4% |
| +39.3% |
| Net Income | -$15.3M | +62.8% | -21.8% |
| EPS (Basic) | -$0.44 | +65.4% | +33.3% |
| EPS (Diluted) | -$0.44 | +65.4% | +33.3% |
| +22.5% |
| +55.2% |
| Current Liabilities | $51.7M | +38.1% | +175.4% |
| Long-term Debt | $195.1M | +59.3% | +97.5% |
| Total Liabilities | $289.8M | +29.2% | +114.4% |
| Stockholders' Equity | $91.1M | +5.2% | -17.4% |